Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (90)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by HAWKINS, C. P.
Right arrow Articles by MCDONALD, W. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HAWKINS, C. P.
Right arrow Articles by MCDONALD, W. I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 114, No. 2, 801-810, 1991
© 1991 Oxford University Press


research-article

PATTERNS OF BLOOD-BRAIN BARRIER BREAKDOWN IN INFLAMMATORY DEMYELINATION

C. P. HAWKINS1, F. MACKENZIE2, P. TOFTS1, E. P. G. H. DU BOULAY1 and W. I. MCDONALD1,

1Multiple Sclerosis NMR Research Group, Institute of Neurology London, UK 2Multiple Sclerosis Society Laboratory, Department of Neurochemistry, Institute of Neurology London, UK

Correspondence to: Correspondence to: Professor W. I. McDonald, Institute of Neurology, Queen Square, London WCIN 3BG, UK.

The evolution of the changes in the blood-brain barrier (BBB) in chronic relapsing experimental allergic encephalomyelitis (CREAE), a model of immune-mediated demyelination, has been studied by magnetic resonance imaging (MRI); gadolinium-DTPA (Gd-DTPA) was used to detect BBB breakdown by both quantitative and qualitative techniques. Animals with acute EAE were examined for comparison. In animals with CREAE an approximately linear relationship was found between the mean number of lesions enhancing with Gd-DTPA seen per MRI slice and the severity of clinical disability at relapse. In addition, a direct relationship was seen between the duration of clinical relapse and the duration of enhancement with Gd-DTPA for lesions associated with the relapse. Lesions studied in animals having entered a progressive phase of disease showed the most sustained BBB breakdown. These observations suggest that BBB breakdown is important in the development of clinical signs in inflammatory demyelination. In CREAE, areas of focal enhancement with Gd-DTPA could usually be clearly defined at a time of clinical relapse. In slices free of focal lesions, no abnormal Gd-DTPA leakage could be detected using a quantitative method. In contrast, in acute EAE no focal lesions were visible, but significant leakage was detected by measurement. No change was found in T2 relaxation times in CREAE or acute EAE.

The pattern of BBB breakdown in inflammatory demyelination evolves from a diffuse shortlived disturbance in acute EAE to a more focal and prolonged breakdown in animals with chronic relapsing and progressive disease. The broad similarities in the pattern of BBB breakdown seen in CREAE and multiple sclerosis support the hypothesis that the initial vascular changes in the human disease are due to inflammation which could be mediated immunologically.

Received December 8, 1989. Revised May 1, 1990. Accepted May 16, 1990.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
P S Piraino, T A Yednock, S B Freedman, E K Messersmith, M A Pleiss, and S J Karlik
Suppression of acute experimental allergic encephalomyelitis with a small molecule inhibitor of {alpha}4 integrin
Multiple Sclerosis, December 1, 2005; 11(6): 683 - 690.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
R. Polavarapu, M. C. Gongora, J. A. Winkles, and M. Yepes
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Increases the Permeability of the Neurovascular Unit through Nuclear Factor-{kappa}B Pathway Activation
J. Neurosci., November 2, 2005; 25(44): 10094 - 10100.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
A. Steinbrecher, T. Weber, T. Neuberger, A. M. Mueller, X. Pedre, G. Giegerich, U. Bogdahn, P. Jakob, A. Haase, and C. Faber
Experimental Autoimmune Encephalomyelitis in the Rat Spinal Cord: Lesion Detection with High-Resolution MR Microscopy at 17.6 T
AJNR Am. J. Neuroradiol., January 1, 2005; 26(1): 19 - 25.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
M. F Lythgoe, N. R Sibson, and N. G Harris
Neuroimaging of animal models of brain disease
Br. Med. Bull., March 1, 2003; 65(1): 235 - 257.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F. Cotton, H. L. Weiner, F. A. Jolesz, and C. R.G. Guttmann
MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals
Neurology, February 25, 2003; 60(4): 640 - 646.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
E. K. Jordan, H. I. McFarland, B. K. Lewis, N. Tresser, M. A. Gates, M. Johnson, M. Lenardo, L. A. Matis, H. F. McFarland, and J. A. Frank
Serial MR Imaging of Experimental Autoimmune Encephalomyelitis Induced by Human White Matter or by Chimeric Myelin-Basic and Proteolipid Protein in the Common Marmoset
AJNR Am. J. Neuroradiol., June 1, 1999; 20(6): 965 - 976.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Calza, L. Giardino, M. Pozza, C. Bettelli, A. Micera, and L. Aloe
Proliferation and phenotype regulation in the subventricular zone during experimental allergic encephalomyelitis: In vivo evidence of a role for nerve growth factor
PNAS, March 17, 1998; 95(6): 3209 - 3214.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
H. E. d. Vries, J. Kuiper, A. G. d. Boer, T. J. C. V. Berkel, and D. D. Breimer
The Blood-Brain Barrier in Neuroinflammatory Diseases
Pharmacol. Rev., June 1, 1997; 49(2): 143 - 156.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.